aNRP2-10

N/A

Report date: 2023/05/30 15:30:38

Base Information

Drug NameaNRP2-10
Drug Alias NameaNRP2-10
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Neuropilin 2
TargetsNeuropilin 2
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAtyr Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAtyr Pharma Inc
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A